Operating
Amortization of capitalized software and acquired intangible assets
Neurocrine Biosciences Amortization of capitalized software and acquired intangible assets decreased by 90.9% to $100.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 90.0%, from $1.00M to $100.00K.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2020
Last reportedQ1 2026May 5, 2026
How to read this metric
Higher levels often follow significant acquisitions, while lower levels suggest a lack of recent intangible asset investment or full amortization of existing assets.
Detailed definition
Amortization is the process of expensing the cost of an intangible asset, such as acquired customer lists or software, o...
Peer comparison
Standard for companies that grow through M&A; peers report this to show the impact of purchase accounting.
Metric ID:
operating_amortization_of_intangible_assetsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $500.00K | $900.00K | $900.00K | $900.00K | $800.00K | $900.00K | $900.00K | $900.00K | $900.00K | $1.00M | $1.00M | $1.00M | $1.10M | $100.00K |
| QoQ Change | — | — | — | — | — | — | — | +80.0% | +0.0% | +0.0% | -11.1% | +12.5% | +0.0% | +0.0% | +0.0% | +11.1% | +0.0% | +0.0% | +10.0% | -90.9% |
| YoY Change | — | — | — | — | — | — | — | — | — | — | +60.0% | +0.0% | +0.0% | +0.0% | +12.5% | +11.1% | +11.1% | +11.1% | +22.2% | -90.0% |
Range$0.00 – $1.10M
Avg YoY Growth+3.8%
Median YoY Growth+11.1%
Amortization of capitalized software and acquired intangible assets at Other Companies
Frequently Asked Questions
- What is Neurocrine Biosciences's amortization of capitalized software and acquired intangible assets?
- Neurocrine Biosciences (NBIX) reported amortization of capitalized software and acquired intangible assets of $100.00K in Q1 2026.
- How has Neurocrine Biosciences's amortization of capitalized software and acquired intangible assets changed year-over-year?
- Neurocrine Biosciences's amortization of capitalized software and acquired intangible assets decreased by 90.0% year-over-year, from $1.00M to $100.00K.
- What does amortization of capitalized software and acquired intangible assets mean?
- The non-cash expense of spreading the cost of intangible assets over time.